Alpha Teknova rose 81.4% in a year. Neogen rose 2.2-fold.

Same industry

TKNO against four same-industry peers, a year at 100

TKNO is up 81.4% in a year. Neogen is up 2.2 times and Lantheus Holdings is up 87.1%. Of these four, Celldex Therapeutics (+21.7%) and Idexx Laboratories (−14.5%) did less. Weekly closes, Oct 10, 2025 = 100, on a log scale so a 2.2-fold rise and a 14.5% fall both read honestly.

Share this chart

TKNO +81.4%. Neogen ×2.2, Lantheus Holdings +87.1%, Celldex Therapeutics +21.7%, Idexx Laboratories −14.5%. Weekly closes, Oct 10, 2025 = 100, log scale.

Share this chart

End-of-day closes (Databento EOD), the last close of each week. The four peers are the largest US-listed companies by market value in TKNO’s SEC industry (In Vitro & In Vivo Diagnostic Substances) with a year of closes. It shows what the closes did; a move here is not a cause, a forecast or a call.

TKNO: stories, the record and filings →